Risk association of orofacial cleft and glucocorticoids exposure during pregnancy: a meta-analysis (GC_OC)

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS26922
• Study ID:
  33602
• Official title and acronym:
  Risk association of orofacial cleft and glucocorticoids exposure during pregnancy: a meta-analysis (GC_OC)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  No information provided.
• Study status:
  Finalised

Research institutions and networks

Institutions

Bayer AG

Study timelines

Date when funding contract was signed

Planned:02/07/2018

Actual:02/07/2018

Study start date

Planned:15/12/2018

Actual:16/11/2018

Date of final study report

Planned:28/02/2020

Actual:28/11/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Bayer AG

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable